Status:

NOT_YET_RECRUITING

A Real-world Clinical Study on the Treatment of Menopausal Syndrome With Liuwei Dihuang Pills

Lead Sponsor:

China Academy of Chinese Medical Sciences

Collaborating Sponsors:

Lanxi Hospital of Traditional Chinese Medicine

First Affiliated Hospital of Harbin Medical University

Conditions:

Menopausal Syndrome

Eligibility:

FEMALE

45-55 years

Brief Summary

To evaluate the clinical efficacy of the real-world Liuwei Dihuang pills for the treatment of female menopausal syndromes, and to provide a basis for effective, safe and rational clinical use of the d...

Detailed Description

In this study, the patients were divided into exposed and non-exposed groups based on whether or not they were taking Liuwei Dihuang Pills. The patients in the non-exposed group were treated routinel...

Eligibility Criteria

Inclusion

  • Age: 45-55 years old
  • Patients with menopausal syndrome using Liuwei Dihuang Pills
  • Kidney Yin Deficiency Syndrome

Exclusion

  • Individuals allergic to any components of the drug or excipients;
  • Individuals with other endocrine diseases;
  • Individuals with organic lesions of the reproductive system;
  • Individuals who have undergone bilateral oophorectomy, hysterectomy, or have ovarian dysfunction;
  • Individuals with endometrial hyperplasia or unexplained vaginal bleeding;
  • Individuals with malignant tumors, hematologic, or immune system diseases;
  • Individuals with severe cardiovascular, cerebrovascular, liver, or kidney diseases (e.g., serum transaminase levels more than 1.5 times the upper limit of normal, serum creatinine above the upper limit of normal);
  • Individuals with psychiatric disorders or dependence on alcohol or drugs;
  • Individuals with mental illness or communication barriers;
  • Individuals with other conditions that, in the investigator's judgment, may reduce the likelihood of enrollment or complicate the study process are not suitable for participation in this clinical research.

Key Trial Info

Start Date :

March 8 2025

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 30 2026

Estimated Enrollment :

1000 Patients enrolled

Trial Details

Trial ID

NCT06874738

Start Date

March 8 2025

End Date

December 30 2026

Last Update

March 13 2025

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.